Rigel Pharmaceuticals, Inc. (RIGL) Posts Q2 Loss of 26c/Share
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $40.79 -2.58%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
OFLX, AFIB, NMRD, More
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
OFLX, AFIB, NMRD, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q2 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $1.4 million versus the consensus estimate of $530 thousand.
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
